# A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure

> **NCT00091520** · PHASE2 · COMPLETED · sponsor: **Scios, Inc.** · enrollment: 920 (actual)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DRUG:** Nesiritide

## Key facts

- **NCT ID:** NCT00091520
- **Lead sponsor:** Scios, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 920 (ACTUAL)
- **Last updated:** 2011-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00091520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00091520, "A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00091520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*